Grant and Funding Programs Offered by Coalition to Cure Prostate Cancer (CTCPC)

The Coalition to Cure Prostate Cancer is a Canadian charitable, philanthropic organization dedicated to accelerating the discovery of better treatments and cures for prostate cancer. Founded in 2011, it operates as a non-profit funder that channels private donations into advanced research carried out by leading Canadian scientists and clinical teams. The organization explicitly describes itself as one that "funds and accelerates advanced research in Canada" and uses a fast-track, low-bureaucracy approach to grant-making so that investigators can focus on breakthroughs rather than paperwork.

The Coalition identifies and invests in promising research programs with strong potential to generate life‑saving results. Projects highlighted on its Research page include translational and clinical studies on neuroendocrine prostate cancer, treatment-resistant disease, drug delivery innovations, and the repurposing of existing medications to delay disease progression. Funding flows to major Canadian research institutions such as the Vancouver Prostate Centre, Princess Margaret Hospital and the Ontario Institute for Cancer Research.

Rather than operating as a broad health charity, the organization concentrates specifically on prostate cancer, supporting work that addresses advanced, lethal and treatment-resistant forms of the disease. Its grants help researchers characterize molecular mechanisms of resistance, develop novel therapeutics and formulations, and design pilot clinical trials that can pave the way for larger, definitive studies.

Grant-making decisions are informed by a Scientific Advisory Committee composed of senior prostate cancer researchers and oncology leaders from Canadian and international institutions. This committee provides expert guidance on scientific priorities, the quality and impact of proposed projects, and the overall research strategy. A separate leadership and board structure, which includes individuals with experience in finance, philanthropy and cancer research, oversees governance, accountability and long‑term direction.

As a registered Canadian charity, the Coalition to Cure Prostate Cancer publishes annual financial statements and tax filings, which detail revenues, expenses and overall use of funds. These documents are accessible through its website, reinforcing transparency for donors, partners and the broader community. The organization emphasizes that donations are put to work quickly through its streamlined grant-making process.

While its primary role is as a research funder, the Coalition also positions itself as a key source of information for Canadian men with prostate cancer and their families. Through its communications, it connects patients, caregivers, clinicians and scientists to critical updates on new standards of care, emerging therapies, best practices and news from the treatment pipeline. By combining targeted research grants with knowledge sharing, the Coalition aims both to improve individual patient outcomes and to advance the overall standard of prostate cancer care in Canada.